Volume 8, Number 10—October 2002
THEME ISSUE
Bioterrorism-related Anthrax
Bioterrorism-related Anthrax
Laboratory Response to Anthrax Bioterrorism, New York City, 2001
Table 2
Site addressc | Pick-up date | Intake date | Item description | Testing location | Urgency | Comments | Swab taken? | |
---|---|---|---|---|---|---|---|---|
FBI | 10/9/2001 | 10/9/2001 | Envelope (Westchester County) | NYCPHL | No | |||
Hospital A | 10/10/2001 | 10/10/2001 | Blood culture | NYCPHL | Stat | No | ||
Hospital B | 10/8/2001 | 10/10/2001 | Request for bacterial culture identification | NYCPHL | Stat | No | ||
FBI | 10/10/2001 | 10/10/2001 | Petri dish | NYCPHL | No | |||
NYPD | 10/11/2001 | One express-mail envelope sealed in plastic, addressed to United Nations | NYCPHL | High | No | |||
FBI | 10/11/2001 | 10/11/2001 | Plastic bag with white powder; business card. | Wadsworth | Low | not enough info | No | |
FBI | 10/11/2001 | 10/11/2001 | Plastic bag containing one envelope with white powder. | Wadsworth | Low | not enough info | No |
aFrom left to right are fields for responder or site of response, site address, date of pick-up, date of intake, bag contents, location of testing, comments, priority, swab taken (yes, no), and patient (if clinical sample). This database allowed the managers to check the progress of sampling and keep track of the “who, what, where, and when” of the samples.
b FBI, Federal Bureau of Investigation; NYCPHL, New York City Public Health Laboratory; NYPD, New York City Police Department; Stat, highest priority for laboratory testing.
cMasked for security purposes.
1 The Joint Microbiological Rapid Response Team consisted of the Biological Defense Research Directorate, Naval Medical Research Center, Bethesda, Maryland: F. Baluyot, M. Boyd, and T. Hudson; 4th Medical Support Squadron, Seymour Johnson Air Force Base, North Carolina, USA: L. M. Bayquen and L. Galloway; and 7th Medical Support Squadron, Dyess Air Force Base, Texas: L. De Los Santos and C. Sekula.
2 The New York City Anthrax Investigation Working Group consisted of Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention (CDC), Fort Collins: May Chu, David Dennis, Kathleen Julian, Anthony A. Marfin, and Lyle Petersen; CDC, Atlanta: Mary Brandt, Richard Kanwal, Kristy Kubota, Els Mathieu, Steve Ostroff, John Painter, Dejana Selenic, Allison Stock, Linda Weigel, and William Wong; New York City Department of Health: Neal Cohen, Laura Mascuch, Denis Nash, Sarah Perl, and Don Weiss; New York City Public Health Laboratories: Alice Agasan, Jay Amurao, Josephine Atamian, Debra Cook, Erica DeBernardo, Adeleh Ebrahimzadeh, Philomena Fleckenstein, Anne Marie Incalicchio, John Kornblum, Ed Lee, William Oleszko, Lynn Paynter, Alexander Ramon, Chiminyan Sathyakumar, Harold Smalls, George Williams, Marie T. Wong, and Ben Y. Zhao.